2014 · CANCER RESEARCH

Characterization of a novel, orally bioavailable, potent and highly selective small molecule inhibitor of PERK: A tool to probe the biphasic concentration-dependent induction of ER stress in models of multiple myeloma and B-cell lymphoma

Stansfield, Ian, Ligny, Yannick, Simonnet, Yvan, Demestre, Christophe, Amblard, Nathalie, Meyer, Christophe, Geerts, Tamara, Van de Ven, Jeroen, Van den Wyngaert, Ilse, Vermeulen, Peter, Beerden, Inge, Peeters, Danielle, Liebregts, Johnny, Van Baelen, Kurt, Simillion, Cedric, Janssen, Boudewijn, Verhulst, Tinne, Esser, Norbert, Bischoff, James, Meerpoel, Lieven, Versele, Matthias